Yongtao W. Duan

100 Kexue Avenue
Zhengzhou, 450001, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 81 publications

Discovery of novel anthraquinone-based P2X7R antagonist that reinvigorates anti-tumor immunity and overcomes PD-1 resistance in breast cancer.

Discovery of novel anthraquinone-based P2X7R antagonist that reinvigorates anti-tumor immunity and overcomes PD-1 resistance in breast cancer.

Journal: European journal of medicinal chemistry
Published: January 06, 2026

DCN-type NEDD8 E3 ligases: Structure, biological function and small-molecule inhibitor.

DCN-type NEDD8 E3 ligases: Structure, biological function and small-molecule inhibitor.

Journal: Pharmacological research
Published: January 05, 2026

Higher levels of neutrophil extracellular traps in mucoid middle ear effusion obtained from otitis media with effusion in children.

Higher levels of neutrophil extracellular traps in mucoid middle ear effusion obtained from otitis media with effusion in children.

Journal: Annals of medicine
Published: November 22, 2025

Discovery of novel aniline-pyrimidine analogues as orally bioavailable dual VEGFR-2/tubulin inhibitors with potent antitumor and anti-angiogenesis efficacy.

Discovery of novel aniline-pyrimidine analogues as orally bioavailable dual VEGFR-2/tubulin inhibitors with potent antitumor and anti-angiogenesis efficacy.

Journal: Bioorganic chemistry
Published: September 09, 2025

The role of P2Y1R in cardiovascular diseases and recent development of P2Y1R antagonists.

The role of P2Y1R in cardiovascular diseases and recent development of P2Y1R antagonists.

Journal: Bioorganic & medicinal chemistry
Published: August 15, 2025

Novel APLNR antagonist candesartan induces tumor vascular normalization through ROS/cGAS/STING axis and augmented sunitinib response in breast cancer.

Novel APLNR antagonist candesartan induces tumor vascular normalization through ROS/cGAS/STING axis and augmented sunitinib response in breast cancer.

Journal: Journal of experimental & clinical cancer research : CR
Published: July 17, 2025

Role of P2Y6R in cancer and its antagonists.

Role of P2Y6R in cancer and its antagonists.

Journal: Drug discovery today
Published: June 13, 2025

Discovery of a novel CD39 inhibitor by DNA-encoded library screening.

Discovery of a novel CD39 inhibitor by DNA-encoded library screening.

Journal: Bioorganic & medicinal chemistry letters
Published: February 15, 2025

Design, Synthesis and Anti-Inflammatory Evaluation of 3-Substituted 5-Amidobenzoate Derivatives as Novel P2Y14 Receptor Antagonists via Structure-Guided Molecular Hybridization.

Design, Synthesis and Anti-Inflammatory Evaluation of 3-Substituted 5-Amidobenzoate Derivatives as Novel P2Y14 Receptor Antagonists via Structure-Guided Molecular Hybridization.

Journal: Journal of medicinal chemistry
Published: January 29, 2025

Discovery of a series of novel 3-sulfonamido benzoic acid derivatives as promising P2Y14R antagonists for acute lung injury.

Discovery of a series of novel 3-sulfonamido benzoic acid derivatives as promising P2Y14R antagonists for acute lung injury.

Journal: European journal of medicinal chemistry
Published: January 22, 2025

The pasteurized Weissella cibaria alleviates sepsis-induced acute lung injury by modulation of intestinal mucus barrier and gut microbiota.

The pasteurized Weissella cibaria alleviates sepsis-induced acute lung injury by modulation of intestinal mucus barrier and gut microbiota.

Journal: Journal of translational medicine
Published: January 13, 2025

Discovery of a potent and in vivo anti-inflammatory Efficacious, P2Y14R antagonist with a novel benzisoxazoles scaffold by DNA-encoded chemical library technology.

Discovery of a potent and in vivo anti-inflammatory Efficacious, P2Y14R antagonist with a novel benzisoxazoles scaffold by DNA-encoded chemical library technology.

Journal: European journal of medicinal chemistry
Published: December 10, 2024
Showing 1-12 of 81

Last Updated: 09/26/2026